Venus Remedies Board Meeting on July 20, 2026, to Approve Q1 FY27 Results

Venus Remedies Ltd has announced that its Board of Directors will convene on July 20, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the meeting will address any other business as permitted by the Chair. In line with insider trading regulations, the trading window for designated persons has been closed from July 1, 2026, and will reopen 48 hours after the financial results are declared.